Home / Mouwasat Medical Services Co. / 2023 Annual Results

Mouwasat Medical Services Co. 2023 Annual Results

Revenue

SAR 2.71B

Net Profit

SAR 658M

EPS

SAR 3.29

Operating Cash Flow

SAR 814M

Mouwasat Medical Services Co. (4002) reported full year 2023 revenue of SAR 2.71B, up 119.0% from SAR 1.24B in 2022. Net profit came in at SAR 658M, up 9.7% year on year. Earnings per share were SAR 3.29. The company generated SAR 814M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.24 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.24.

Key Financial Metrics

Metric	2023	2022
Revenue	SAR 2.71B	SAR 1.24B
Net Profit	SAR 658M	SAR 599M
Gross Profit		SAR 1.10B
Net Margin	24.3%	48.5%
ROE	20.1%	20.5%
EPS	SAR 3.29
Total Assets	SAR 4.96B	SAR 4.66B
Total Equity	SAR 3.28B	SAR 2.92B
Total Liabilities	SAR 1.54B
Operating Cash Flow	SAR 814M

Year on Year Comparison

Revenue increased by 119.0% compared to 2022. Net profit increased by 9.7%. Both revenue and profit grew — indicating expanding business.

View full company profile →

View all years:

2025 2024 2023 2022 2021 2020 2019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2024-03-25.